Entera Bio ENTX Stock
Entera Bio Price Chart
Entera Bio ENTX Financial and Trading Overview
| Entera Bio stock price | 2.04 USD |
| Previous Close | 0.82 USD |
| Open | 0.84 USD |
| Bid | 0 USD x 2900 |
| Ask | 0 USD x 3100 |
| Day's Range | 0.8 - 0.85 USD |
| 52 Week Range | 0.47 - 2 USD |
| Volume | 37.8K USD |
| Avg. Volume | 57.36K USD |
| Market Cap | 24.2M USD |
| Beta (5Y Monthly) | 1.828254 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.31 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.67 USD |
ENTX Valuation Measures
| Enterprise Value | 13.56M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.1051316 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 366.68 |
| Price/Book (mrq) | 2.3997145 |
| Enterprise Value/Revenue | 205.422 |
| Enterprise Value/EBITDA | -1.15 |
Trading Information
Entera Bio Stock Price History
| Beta (5Y Monthly) | 1.828254 |
| 52-Week Change | -49.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2 USD |
| 52 Week Low | 0.47 USD |
| 50-Day Moving Average | 0.85 USD |
| 200-Day Moving Average | 0.91 USD |
ENTX Share Statistics
| Avg. Volume (3 month) | 57.36K USD |
| Avg. Daily Volume (10-Days) | 24.14K USD |
| Shares Outstanding | 28.81M |
| Float | 19.57M |
| Short Ratio | 0.77 |
| % Held by Insiders | 23.04% |
| % Held by Institutions | 10.63% |
| Shares Short | 32.83K |
| Short % of Float | 0.13% |
| Short % of Shares Outstanding | 0.11% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -17956.061% |
| Gross Margin | 28.78% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -43.67% |
| Return on Equity (ttm) | -76.96% |
Income Statement
| Revenue (ttm) | 66K USD |
| Revenue Per Share (ttm) | 0.002 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 33K USD |
| EBITDA | -11789000 USD |
| Net Income Avi to Common (ttm) | -11477000 USD |
| Diluted EPS (ttm) | -0.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.69M USD |
| Total Cash Per Share (mrq) | 0.37 USD |
| Total Debt (mrq) | 48K USD |
| Total Debt/Equity (mrq) | 0.48 USD |
| Current Ratio (mrq) | 7.612 |
| Book Value Per Share (mrq) | 0.35 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9316000 USD |
| Levered Free Cash Flow (ttm) | -5476875 USD |
Profile of Entera Bio
| Country | United States |
| State | N/A |
| City | Jerusalem |
| Address | Kiryat Hadassah Minrav Building |
| ZIP | 9112002 |
| Phone | 972 2 532 7151 |
| Website | https://www.enterabio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 18 |
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. Its other product candidate is GLP-2, which is in preclinical trial for the treatment of short bowl syndrome; and hGh for the GH deficiency. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
Q&A For Entera Bio Stock
What is a current ENTX stock price?
Entera Bio ENTX stock price today per share is 2.04 USD.
How to purchase Entera Bio stock?
You can buy ENTX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Entera Bio?
The stock symbol or ticker of Entera Bio is ENTX.
Which industry does the Entera Bio company belong to?
The Entera Bio industry is Biotechnology.
How many shares does Entera Bio have in circulation?
The max supply of Entera Bio shares is 51.84M.
What is Entera Bio Price to Earnings Ratio (PE Ratio)?
Entera Bio PE Ratio is now.
What was Entera Bio earnings per share over the trailing 12 months (TTM)?
Entera Bio EPS is -0.31 USD over the trailing 12 months.
Which sector does the Entera Bio company belong to?
The Entera Bio sector is Healthcare.
Entera Bio ENTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}